BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17537309)

  • 21. [Establishment of cisplatin-resistant human endometrial cancer cell line and the study of its resistant mechanisms].
    Xu QY; Chen YH; Zhao LJ; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):533-7. PubMed ID: 22041447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemosensitivity test on hepatocellular carcinoma (HCC) and drug resistance].
    Ishimura H
    Hokkaido Igaku Zasshi; 1996 Nov; 71(6):689-98. PubMed ID: 8996838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Establishment of a cisplatin-resistant human cervical cancer cell line].
    Chen XL; Wang H; Zhang XM; Liu HQ; Liu SL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):151-5. PubMed ID: 22650020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma].
    Ueda M; Misaki O; Yamada T; Okamoto Y; Goto M; Maeda T; Okamura S; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1423-30. PubMed ID: 2531191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of U-73,975 and cisplatin cytotoxicity in fresh cervical and ovarian carcinoma specimens with the ATP-chemosensitivity assay.
    Hightower RD; Sevin BU; Perras JP; Untch M; Angioli R; Ramos R; Averette H
    Gynecol Oncol; 1992 Nov; 47(2):186-90. PubMed ID: 1468696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues].
    Han J; Tan BB; Geng W; Lu BR; Zhao JH
    Ai Zheng; 2008 Nov; 27(11):1166-71. PubMed ID: 19000447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ATP-tumor chemosensitivity assay directed chemotherapy in patients with cervical cancer].
    Zhang Y; Zhao Q; Jiang Y; Yuan Z; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 38(12):1223-7. PubMed ID: 24384959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression features of P-glycoprotein, glutathione S transferase-pi and inhibitor of apoptosis proteins in lymph node metastases of gastrointestinal carcinomas].
    Han J; Tan BB; Wang AF; Lü BR; Geng W; Zhao JH; He CN
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):106-8. PubMed ID: 19563003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA).
    Whitehouse PA; Knight LA; Di Nicolantonio F; Mercer SJ; Sharma S; Cree IA;
    Anticancer Drugs; 2003 Jun; 14(5):369-75. PubMed ID: 12782944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
    Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
    J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer].
    Han B; Liao M; Su J; Feng J; Wang E; Dong Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):727-31. PubMed ID: 12622891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
    Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.
    Xue F; Xu Y; Song Y; Zhang W; Li R; Zhu X
    Drug Des Devel Ther; 2019; 13():3919-3928. PubMed ID: 31819366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of ATP based bioluminescence tumor chemosensitivity assay in the chemotherapy of pediatric solid tumor].
    Cheng HY; Zhu XD; Wang HM; Qin H
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):598-603. PubMed ID: 19951493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W; Gu M; Liang L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.